Cancer Immunology, Immunotherapy

, Volume 56, Issue 1, pp 70–80

The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines

Authors

  • Deepak P. Assudani
    • School of Biomedical and Natural SciencesNottingham Trent University
  • Roger B. V. Horton
    • School of Biomedical and Natural SciencesNottingham Trent University
  • Morgan G. Mathieu
    • School of Biomedical and Natural SciencesNottingham Trent University
  • Stephanie E. B. McArdle
    • School of Biomedical and Natural SciencesNottingham Trent University
    • School of Biomedical and Natural SciencesNottingham Trent University
Symposium Paper

DOI: 10.1007/s00262-006-0154-6

Cite this article as:
Assudani, D.P., Horton, R.B.V., Mathieu, M.G. et al. Cancer Immunol Immunother (2007) 56: 70. doi:10.1007/s00262-006-0154-6

Abstract

Recent years have seen the unprecedented surge of interest in the role of CD4+ T cells and the role they play in the development of the immune response. In this symposium review, we examine the evidence for this and discuss their functions, particularly in respect to the cancer immunology, including CD4+CD25+ cells (Treg).

Copyright information

© Springer-Verlag 2006